NTRA Stock Analysis: Buy, Sell, or Hold?
NTRA - Natera, Inc. Common Stock
$231.14
-0.34 (-0.15%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When NTRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called NTRA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NTRA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: NTRA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: NTRA is currently trading at $231.14, which is considered oversold relative to its 30-day fair value range of $231.16 to $243.07.
Technical Outlook: Technically, NTRA is in a strong uptrend. The price is currently testing key support at $226.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $257.20 (+11.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NTRA is in a strong uptrend. The price is currently testing key support at $226.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $257.20 (+11.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$231.16 -
$243.07
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($257.20)
Fair Price Analysis
30-Day Fair Range
$231.16 -
$243.07
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$13.73
(5.9%)
Support & Resistance Levels
Support Level
$226.66
Resistance Level
$250.00
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-116.53
Wall Street Target
$257.20
(+11.1%)
Revenue Growth (YoY)
34.7%
Profit Margin
-14.6%
Last updated: January 31, 2026 3:06 PM ET
Data refreshes hourly during market hours. Next update: 4:06 PM
Data refreshes hourly during market hours. Next update: 4:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRA showing a specific setup today?
Insider Activity (6 Months)
2
Buys
16
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Burkes Brophy
SELL
755 shares
2025-10-24
Michael Burkes Brophy
SELL
495 shares
2025-10-23
Michael Burkes Brophy
SELL
920 shares
2025-10-22
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$261 | 59 HOLD |
Advanced NTRA Option Strategies
Professional options setups generated by AI based on today's NTRA price and gamma walls.
